The analysis was also performed on total memory CD4+ T cells obtained ex vivo from peripheral blood mononuclear cells (PBMCs) from patients with GBS, as well as from publicly available datasets from healthy donors or patients with other autoimmune disorders27–29 (Supplementary Table 3). This evidence concerns the gene CD4 and Guillain-Barre syndrome.